GRACE SANTOS NILO, MD, FPCP, FPSMO

Unit **-B, Tower 2, The Columns Legazpi, Arnaiz Ave. corner Amorsolo st.,

Legaspi Village, Makati City, Philippines

+63-917*******

+63 2 9551541

acw2fg@r.postjobfree.com

GENERAL INFORMATION

Passed the Physician Licensure Exam in 2000

Passed the Philippine College of Physicians (PCP) Diplomate Board Exams in 2005

Passed the Philippine Society of Medical Oncology (PSMO) Diplomate Board Exams in 2010

Diplomate and Fellow, Philippine Society of Medical Oncology

Dipllomate and Fellow, Philippine College of Physicians

Born on 29 December 1974

*EXPERTISE

CLINICAL – general medical oncology including diagnosis and management of oncologic cases; hands-on preparation and administration of chemotherapeutic regimens; palliative care

CORPORATE - overall management and direction of Medical Affairs; start-up and monitoring of clinical trials to ensure timely delivery of milestones; provision of medical / scientific expertise regarding pertinent brands / associated disease areas (both marketed and pre-launch products) ; provision of medical information to HCPs; compliance of BU to both internal and external (PHAP) policies; collaboration with patient groups to enhance market access

CLINICAL / CORPORATE EXPERIENCE

Visiting Consultant

(Medical Oncologist)

Head of Medical Affairs / Chief Scientific Officer /

Franchise Lead for Hematology

Ad-interim Head of Medical Affairs, Medical Adviser, MSL

Franchise Lead / Medical Adviser for Solid Tumors

Active Consultant

(Medical Oncologist)

In-house medical oncologist

Fellow-in-Training

St. Luke’s Medical Center – Global City

Novartis Healthcare Philippines –

Oncology Business Unit

Novartis Healthcare Philippines –

Oncology Business Unit

Novartis Healthcare Philippines –

Oncology Business Unit

Nationwide Health Sytems, Inc.

Philippine Infusion Center, Makati

St. Luke’s Medical Center – Global City

Section of Medical Oncology,

Department of Medicine, University of

the Philippines-Philippine General Hospital

June 2015 to present

Feb 2015 to present

Feb 2014 to Jan 2015

Feb 2013 to Jan 2014

Feb 2013 to Sept 2015

September 2010 to Feb 2013

March 2008 to March 2010

In-house physician

Reliever status

Sta. Lucia Health Care Clinic

2007 to 2008

Emergency Room Officer

Cardinal Santos Medical Center

June to August 2004

Resident –in-Training

Department of Medicine, Cardinal

Santos Medical Center

January 2001 to December 2003

Medical Intern

Cardinal Santos Medical Center

1999 to 2000

PARTICIPATION IN CLINICAL TRIALS

Sponsor

Sub-investigator (during fellowship training)

*Novartis Oncology

The Observational Registry Collecting Data on Gastroenteropancreatic Neuroendocrine Tumor Patients (GEP-NET Registry) CSMS995AIC01

Myeloproliferative neoplasms Epidemiological Registry in Growing and Emerging markets "The MERGE Study" CINC424AiC01

An open-label, muti-center, Expanded Treatment Protocol (ETP) of oral LDK378 in adult patients with non-small cell lung cancer (NSCLC) characterized by ALK positivity

A randomized, open-label, multicenter, two arm, phase II study to evaluate treatment compliance, efficacy and safety of an improved deferasirox formulation (granules) in pediatric patients with iron overload

A Randomized, Multi-Centre, Open label, Phase III Study of Adjuvant lapatinib,trastuzumab, their sequence and their combination in patients with HER2/ ErbB2 positive primary breast cancer (ex-GSK)

An Open-Label, Phase II, Study to Evaluate Biomarkers Associated with Response to Subsequent Therapies in Subjects with HER2-Positive Metastatic Breast Cancer Receiving Treatment with Trastuzumab in Combination with Lapatinib or Chemotherapy (EGF117165)

*GSK

A Randomized, Multicenter, Phase III Study Comparing the Combination of Pazopanib and Lapatinib versus Lapatinib Monotherapy in Patients with ErbB2 Over-expressing Inflammatory Breast Cancer

*Pfizer

A Multinational, Randomized, Open-Label, Phase III Study of Sunitinib Malate versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma

*Roche

A Multicenter Phase III Randomized Trial of Adjuvant Therapy for Patients with HER2-Positive Node-Positive or High Risk Node-Negative Breast Cancer Comparing Chemotherapy Plus Trastuzumab with Chemotherapy Plus Trastuzumab Plus Bevacizumab

RESEARCH AND PUBLICATIONS

The Economic Impact of Adding Capecitabine to Herceptin-Docetaxel Combination in the First Line Treatment of Metastatic Breast Cancer Patients in a Non-Reimbursed Health Care System (PTioleco, GNilo, STanael)

Prognostic Factors and Treatment Outcomes of Nasopharyngeal Cancer Patients Seen at the University of the Philippines-Philippine General Hospital Cancer Institute from March 2008 to March 2009 (GNilo, BTiangco)

November 2009

Poster Presentation, Roche Asia Oncology Forum, Cebu, Philippines

March 2010

Winner, Paper Presentation

Asia Pacific Oncology Summit

Tokyo, Japan

October 2009

Second place, Oral Presentation, PSMO Annual Convention

November 2009

Poster Presentation, Roche Asia Oncology Forum, Cebu, Philippines

A Clinico-pathological Profile of Males versus Females with Lung Cancer (CPVilla, GNilo, CNgelangel)

October 2009

Poster Presentation, PSMO Annual Convention

November 2009

Top 20, Poster Presentation, Roche Asia Oncology Forum, Cebu, Philippines

Inflammatory Bowel Disease: The Philippine Perspective (JSollano, RLopez, JCo, GNilo, FAntonio, VAng, SAlvarez, RCarpio, MChan, FDy, LGarcia, JGo, AIsmael, VLim, ERuiz, EOng, JPerez, CTady, SWong, JTan, JBautista)

March 2006

Poster Presentation, Falk Symposium 151, Sydney, Australia

Is Viral Load Reduction with Nucleoside Analogue Treatment Associated with Improvement in Necroinflammatory Scores in Chronic Hepatitis B Infection? (JSollano, JCo, GNilo, FDy, SWong, ALay, JClavio, JBautista)

March 2006

Second place, Oral Paper Presentation, PSG–PSDE 26th Joint Annual Convention

Genotypic Characteristics of Filipino Patients with Chronic Hepatitis C Virus Infection (JSollano, JCo, GNilo, WAntonio)

March 2006

Poster Presentation, 16th Asia Pacific Association for the Study of the Liver (APASL) Convention, Manila, Philippines

Clinical Profile of Chronic Hepatitis B Patients with Genotype C Subtype Cp (JSollano, YTanaka, JCo, GNilo, FWAntonio, AQuino, TSakamoto, SWong, ALay, JClavio, MMizokami)

March 2006

Poster Presentation, 16th APASL Convention, Manila, Philippines

Hepatitis B Virus Genotypes and Hepatocellular Carcinoma in the Philippines (JSollano, YTanaka, JCo, GNilo, FWAntonio, AQuino, TSakamoto, SWong, ALay, JClavio, MMizokami)

March 2006

Poster Presentation, 16th APASL Convention, Manila, Philippines

The Synergism of Risk Factors for Hepatocellular Carcinoma in a Filipino Population - A Case-Control Study (DPayawal, GNilo, KYuKimTeng, JSollano, EBondoc, SAlvarez)

May 2004

Poster Presentation, PCP 34th Annual Convention

March 2004

Fourth place, Oral Paper Presentation, PSG–PSDE 24th Joint Annual Convention

Impact of Ablation Therapy on the Clinical Outcome of Patients with Well-Differentiated Hepatocellular Carcinoma (DPayawal, GNilo, SAlvarez, JSollano, EBondoc)

March 2004

Published, Philippine Journal of Gastroenterology (Maiden Issue)

November 2003

Finalist, Oral Paper Presentation, Philippine Society of Oncology

November 2003

Poster Presentation, Falk Symposium, Germany

October 2003

First prize, Oral Paper Presentation, Philippine Society of Medical Oncology

March 2003

Third prize, Oral Paper Presentation, PSG–PSDE 23rd Joint Annual Convention

November 2002

Second prize, Interdepartmental Oral Paper Presentation, Cardinal Santos Medical Center

October 2002

Second prize, Intradepartmental Oral Paper Presentation, Cardinal Santos Medical Center

Human Chorionic Gonadotropin (hCG) and Its Subunits As Possible Tumor Marker for Lung Cancer (GBernas, IGarcia, GNilo)

March 1994

Second prize, Oral Paper Presentation, Department of Chemistry, College of Science, University of

Santo Tomas

ABSTRACTS SUBMITTED TO APASL MANILA

DNA Levels and Histologic Response in Filipino Chronic Hepatitis B Patients Treated with Nucleoside Analogues (JSollano, JCo, GNilo, FDy, SWong, ALay, JClavio, JBautista)

March 2006

DNA Reduction in Chronic Hepatitis B Patients Treated with Entecavir versus Lamivudine (JSollano, JCo, GNilo, FDy, SWong, ALay, JClavio, JBautista)

March 2006

Utility of Serum Alphafetoprotein in Predicting Survival of Patients Diagnosed With Hepatocellular Carcinoma (DPayawal, ILapus, JCo, GNilo)

March 2006

EDUCATION

University of the Philippines

College of Medicine

March 2008 to March 2010

Master of Science in Clinical Medicine (Medical Oncology)

University of the Philippines

College of Public Health

June to August 2004

Master of Science in Epidemiology (incomplete)

University of Santo Tomas

College of Medicine

Class of 1999

Doctor of Medicine

University of Santo Tomas

College of Science

Class of 1994

B.S. Chemistry

CONFERENCES, WORKSHOPS, LECTURES AND CONVENTIONS ATTENDED*

U.P.Manila – National Institutes of Health 26-28 Aug 2015

Principles of Health Research Ethics and

Good Clinical Practice (Basic Course)

51st American Society of Clinical Oncology 29 May 2013 and 2015

Annual Meeting (Chicago)

Medical Development in Region Europe 16 March 2015

(Como, Italy)

CML / MPN GOLS 27 February 2015

(Global Opinion Leaders Summit)

(Berlin, Germany)

56TH American Society of Hematology 6 December 2014

Annual Meeting (San Francisco)

Asian Oceania Congress of Endocrinology 8 October 2014

(Cebu)

CML / MPN GOLS 7 March 2014

(Amsterdam)

Principles of Health Research Ethics 29 November 2013

and Good Clinical Practice

(UP Manila – NIH)

GIST/NET GOLS 15 November 2013

(Helsinki, Finland)

Novartis Oncology Publication Training 9 November 2013

Workshop (Hyderabad, India)

Novartis Oncology Asia Pacific Summit 6 July 2013

(Shanghai, China)

Mass Casualty Incident 25 October 2012

and Triage Orientation

(SLMC-GC)

Advance Cardiac Life Support 9 March 2012

Re-certification Course

(SLMC-GC)

Customer Service Champion Workshop 11 July 2011

(SLMC-GC)

Department of Finance 29 April 2010

Anniversary Week

**lecturer

(Bangko Sentral ng Pilipinas)

Cancer Consciousness Week January 2010

Cancer Institute

(U.P. – Philippine General Hospital)

**lecturer

8th Roche Asia Oncology Forum

(Cebu)

6 to 7 November 2009

Unraveling the Biomarker Story: Towards Evidentiary Standards for Clinical Utility

(Department of Epidemiology and Biostatistics, College of Public Health, University of the Philippines)

25 April 2009

Understanding Survival in Oncology Quality Care

(Department of Epidemiology and Biostatistics, College of Public Health, University of the Philippines)

15 November 2009

Principles of Good Clinical Practice (GCP) and Research Ethics for Physicians and Clinical Trialists

(Sanofi-Aventis Makati)

6 November 2009

PSMO HER2 Testing Teaching Lecture

21 October 2008

8th International Conference of the Asian Clinical Oncology Society

21 to 24 September 2008

*Excludes Philippine College of Physicians (PCP) and Philippine Society of Medical Oncology (PSMO) Mid-year and Annual Conventions - yearly attendance

ORGANIZATIONS / SOCIETY AFFILIATIONS

Philippine Medical Association

Philippine College of Physicians

Member, Research Committee - Annual Convention 2016

Philippine Society of Medical Oncology

Member, Research Committee - Annual Convention 2014

Co-chair, Research Committee - Annual Convention 2015

Co-chair, Research Committee - Annual Convention 2016

Philippine College of Pharmaceutical Medicine

CHARACTER REFERENCES

RESIDENCY / FELLOWSHIP TRAINING

Corazon A. Ngelangel, M.D. Gerardo H. Cornelio, M.D.

Chief Training Officer

Section of Medical Oncology Section of Medical Oncology

U.P. – Philippine General Hospital U.P.-Philippine General Hospital

Taft Avenue, Manila Taft Avenue, Manila

# +63.2.5263775 # +63.2.5263775

Jorge G. Ignacio, M.D. Diana A. Payawal, M.D.

Chairman, Cancer Institute Chief Training Officer

U.P.-Philippine General Hospital Cardinal Santos Medical Center

Taft Avenue, Manila Wilson St., San Juan, Metro Manila

# +63.2.5263775 # +63.2.7270001

ST. LUKE’s MEDICAL CENTER – GLOBAL CITY

Antonio H. Villalon, M.D. Melvin A. Parungao, R.N.

Past Director – Cancer Institute Head Oncology Nurse, Ambulatory Care Unit

SLMC – Global City SLMC – Global City

Taguig Taguig

# +63.2.7897700 # + 63.2.7897700

Contact this candidate